OpenAI removes DALL-E waitlist, allowing anyone to sign up, and tests API
OpenAI announced today that the research laboratory is removing the waitlist for its DALL-E beta, citing improved safety systems.Read More
OpenAI announced today that the research laboratory is removing the waitlist for its DALL-E beta, citing improved safety systems.Read More
Ya Xu, head of AI at LinkedIn, shares her thoughts on collaboration, responsible AI and the top traits of data science talent.Read More
Intel announces that Accenture and Leidos have begun testing its confidential computing solution, Project Amber, for healthcare use cases.Read More
Human-centered design starts with “who” will be impacted by a product or experience, rather than “how” to build a new revenue stream.Read More
During the first session of Re:WIRED GREEN, experts laid out their vision for maintaining hope in the face of unprecedented challenges to our planet.
Younger people seek answers on TikTok and Instagram—Google hopes to lure them back with more visual, infinite scrolling search results.
Damage to the pipeline that runs between Russia and Germany is being treated as deliberate. Finding out what happened may not be straightforward.
Yes, we saw the usual spate of Echo speakers, but there’s also a brand-new stylus-powered Kindle you can doodle on.
The company’s new smart gadget uses radar to track your breathing while you sleep. It’s part of Amazon’s plan to weave its products invisibly into your life.
Developing life-saving medicines can take billions of dollars and decades of time, but researchers are aiming to speed up this process with a new artificial intelligence-based drug screening process they’ve developed. Using a method that models drug and target protein interactions using natural language processing techniques, the researchers achieved up to 97% accuracy in identifying …
Read more “AI-based screening method could boost speed of new drug discovery”